Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Our Work > All Publications > 2006


Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

Find an article or report or see all by area, author, or year:


Removing Barriers to Global Pandemic Influenza Vaccination

Gigi Kwik Gronvall, Luciana Borio
Date posted:
June 15, 2006
Publication type:

Biosecur Bioterror 2006;4(2):168-175

Mary Ann Liebert, Inc.
Available on publisher's website
See also:

Full article as PDF


This article clarifies the regulatory issues surrounding influenza pandemic vaccine for the larger policy community and describes the need for regulatory harmonization. Vaccination would save lives in an influenza pandemic, but a lack of global manufacturing capacity will leave most of the world without access to vaccine. Capacity can be expanded if governments harmonize their regulatory policies. This article details the regulatory approaches taken by the United States, the European Union, and Japan for pandemic vaccine development, three regions that produce the majority of the world’s seasonal influenza vaccine. They should quickly converge on regulatory requirements, intellectual property considerations, the use of recombinant DNA techniques for vaccine production, and technical issues about the composition of pandemic vaccine.

Full article as PDF



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.